AAA
REGN icon

American Alpha Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

American Alpha Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362K Buy
468
+2
+0.4% +$1.53K 0.19% 78
2025
Q4 		$360K Buy
466
+75
+19% +$50.9K 0.21% 69
2025
Q3 		$220K Sell
391
-28
-7% -$15.8K 0.15% 84
2025
Q2 		$220K Buy
419
+77
+23% +$43K 0.17% 80
2025
Q1 		$217K Buy
+342
New +$235K 0.18% 82

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

American Alpha Advisors's REGN Position: Q1 2026 in Review

American Alpha Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 0.43% in Q1 2026, buying an estimated $1.53K and bringing the position to 468 shares worth $362K. The position accounts for 0.19% of the portfolio, ranked #78.

American Alpha Advisors first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • American Alpha Advisors held 468 shares of Regeneron Pharmaceuticals worth $362K as of Q1 2026.
  • American Alpha Advisors bought 2 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.53K.
  • Regeneron Pharmaceuticals made up 0.19% of American Alpha Advisors's portfolio in Q1 2026, its #78 holding.
  • American Alpha Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on American Alpha Advisors's 13F filing for Q1 2026, filed 15 May 2026.